{"id":1004,"date":"2016-12-20T02:43:58","date_gmt":"2016-12-20T09:43:58","guid":{"rendered":"http:\/\/4abettermemory.com\/memory\/?p=1004"},"modified":"2016-12-20T03:23:26","modified_gmt":"2016-12-20T10:23:26","slug":"new-insurance-against-alzheimers-decline","status":"publish","type":"post","link":"https:\/\/4abettermemory.com\/memory\/new-insurance-against-alzheimers-decline\/","title":{"rendered":"New Insurance Against Alzheimer\u2019s Decline"},"content":{"rendered":"<p>This is an a<img loading=\"lazy\" decoding=\"async\" class=\"size-thumbnail alignleft\" src=\"http:\/\/www.lifeextension.com\/magazine\/mag2016\/images\/ss16_otc1_harbai_03.jpg\" width=\"150\" height=\"180\" \/>daptation of a recent news release from Life Extension Foundation, revealing a novel\u00a0<strong>low-cost<\/strong>\u00a0method of restoring\u00a0<strong>cognitive function<\/strong> lost to structural changes that can occur in aging brains, especially those with Alzheimer disease (AD). The primary biomarkers for AD are deformed amyloid proteins, associated with sticky plaque accumulations in the brain, and tangled strands of another essential protein called tau. Millions of dollars have been spent trying to find ways to prevent these abnormal formations.<\/p>\n<p>Now two simple nutrients have been found to stabilize and arrest both of these, with resulting improvements in functional abilities like remembering and conversing. These two nutrients are <strong>low dose lithium<\/strong> and a <strong>Proline-rich polypeptide derived from<\/strong><strong> colostrum,<\/strong><strong> a component of mother\u2019s milk.<\/strong><\/p>\n<p><strong><u>Lithium<\/u><\/strong>\u00a0acts by inhibiting an\u00a0<em><strong>enzyme<\/strong><\/em>\u00a0called\u00a0<strong>GSK-3<\/strong>\u00a0that causes the formation of abnormal <strong>tau proteins<\/strong><sup>39 <\/sup>and their\u00a0\u201c<strong>neurofibrillary tangles<\/strong>.\u201d You may recall from class, that tau proteins hold together the microtubules that transport materials within and between cells. \u00a0Therefore, if the tau in our brain become damaged, they can detach, become tangled, and the cells they support will die. Consequently, any function these cells supported will suffer. It could be hearing, memory, or something else.<sup>40,41 <\/sup>\u00a0But lithium, it appears, can help arrest this cascade of adverse events.<\/p>\n<p><strong><u>Colostrum-derived<\/u><\/strong>\u00a0<strong><u>Proline-rich polypeptides<\/u><\/strong> alter the expression of genes involved in\u00a0<strong>beta amyloid<\/strong>\u00a0formation and in\u00a0<strong>tau protein<\/strong>\u00a0damage.<sup>42,43\u00a0 <\/sup>Additionally it\u2019s been found to effect an increase in <strong>new nerve cell growth and connectivity<\/strong>.<sup>43,44<\/sup><\/p>\n<p>As a result his extract has been shown to produce\u00a0<strong>improvements<\/strong>\u00a0in cognitive function and activities of daily living in\u00a0<strong>human<\/strong>\u00a0studies. Moreover, the mechanisms by which these nutrients protect the\u00a0<strong>brain<\/strong>\u00a0may confer similar benefits to cells in other parts of the body, providing new avenues for addressing several of the underlying causes of degeneration as we age. (If you are in a hurry arrow down to heading\u00a0<em><strong>Human Study Shows<\/strong><\/em>&#8230;)<\/p>\n<h4>GSK-3: The Age-Accelerating Enzyme<\/h4>\n<p><strong>Among other things, GSK-3<\/strong><strong>\u00a0<\/strong>plays a role in regulating\u00a0<strong>glucose<\/strong>\u00a0metabolism. An important factor in brain health. GSK-3 stands for\u00a0<em><strong>glycogen synthase kinase-3<\/strong><\/em>. One problem then with\u00a0<em><strong>GSK-3<\/strong><\/em>\u00a0as we age is that it allows sugars to severely damage proteins that maintain delicate cellular structures. Here\u2019s a description of what scientists find when\u00a0<strong>GSK-3<\/strong>\u00a0activity is increased:<\/p>\n<ol>\n<li>Accelerated aging in heart and muscle, showing profound dysfunction.<\/li>\n<li>Increase in pro-inflammatory cytokines.<\/li>\n<li>Accelerated aging in the skeletal system, leading to degenerative joint disease.<\/li>\n<li>Accelerated aging in the stomach and liver.<\/li>\n<li>Development of structurally abnormal cell organelles including disrupted mitochondria.<\/li>\n<li>The inability to clear \u201cdebris\u201d that accumulates inside aging cells.<\/li>\n<li>Development of\u00a0<strong>type II diabetes<\/strong>,<sup>46<\/sup><strong>Alzheimer\u2019s<\/strong> and other disorders of aging.<sup><sup>47<\/sup><\/sup><\/li>\n<\/ol>\n<p>You are about to learn a new term that may soon become as widely known as \u201c<strong>antioxidant<\/strong>.\u201d\u00a0This new longevity strategy is to identify safe substances that function as\u00a0<strong>GSK-3 inhibitors<\/strong>. Studies show that when\u00a0<strong>GSK-3<\/strong>\u00a0is inhibited, healthy brain function and\u00a0<strong>lifespan<\/strong>\u00a0may be increased.<sup>48<\/sup><\/p>\n<h4>How GSK-3 Contributes to Alzheimer\u2019s disease<\/h4>\n<p>As noted above, the brains of individuals afflicted with AD show accumulations of\u00a0<em><strong>beta amyloid<\/strong><\/em>\u00a0plaque and damaged\u00a0<em><strong>tau proteins<\/strong><\/em>.<sup>49<\/sup>\u00a0This in turn creates <em><strong>neurofibrillary tangles<\/strong><\/em>\u00a0that lead to the cell death and brain\u00a0<em><strong>shrinkage<\/strong><\/em>\u00a0associated with\u00a0<strong>Alzheimer\u2019s<\/strong>.<sup>50<\/sup> <sup>\u00a0<\/sup>Moreover, this new research now shows these <strong>structural<\/strong>\u00a0alterations in brain cells correlate with increased activity of the\u00a0<strong>GSK-3<\/strong><strong>\u00a0<\/strong>enzyme.<\/p>\n<p><strong>GSK-3<\/strong>\u00a0converts\u00a0<em><strong>tau proteins<\/strong><\/em>\u00a0into destructive tangled clumps or\u00a0<em><strong>neurofibrillary tangle<\/strong><\/em>s that starve brain cell to death, eventually leading to dementia.<sup>39,50,51<\/sup><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"http:\/\/www.lifeextension.com\/magazine\/mag2016\/images\/ss16_otc1_harbai_01.jpg\" width=\"150\" height=\"180\" \/><\/p>\n<p>Evidence suggests that impaired\u00a0<strong>glucose\/insulin<\/strong>\u00a0action increases accumulations of\u00a0<em><strong>beta amyloid<\/strong><\/em>\u00a0and damaged\u00a0<em><strong>tau<\/strong><\/em>\u00a0<em><strong>proteins<\/strong><\/em>.<sup>50 <\/sup>These observations have led to the term\u00a0<em><strong>\u201ctype III diabetes\u201d<\/strong><\/em>\u00a0being used to describe Alzheimer\u2019s disease. That\u2019s because so many Alzheimer\u2019s patients also present with\u00a0<strong>glucose impairment<\/strong>\u00a0and\u00a0<strong>insulin resistance<\/strong>.<sup>52,53<\/sup><\/p>\n<p>Studies have now shown that by inhibiting\u00a0<strong>GSK-3<\/strong>\u00a0activity, one can effectively lower blood\u00a0<strong>glucose\u00a0<\/strong>in diabetic animals, while increasing\u00a0<strong>insulin sensitivity<\/strong>.<sup>54,55<\/sup><\/p>\n<p>Since Alzheimer\u2019s patients frequently suffer from abnormal sugar and insulin action in their brains, this has led to the idea that\u00a0<em><strong>GSK-3 inhibition<\/strong><\/em><strong><em>\u00a0<\/em><\/strong>might be a useful approach\u00a0 in\u00a0<strong>Alzheimer\u2019s disease<\/strong>, as well as diabetes<sup>51<\/sup>\u00a0In fact, the title of a comprehensive scientific report on this topic is:<\/p>\n<h5><strong>Lithium: A GSK-3 Inhibitor<\/strong><\/h5>\n<p>Lithium\u00a0has a long history in medicine as a psychoactive drug used to treat bipolar disorder, depression, and other illnesses. \u00a0But it\u2019s actually a naturally occurring element present in most drinking water.<br \/>\nFortunately, we don\u2019t have to wait for some new drug to inhibit <strong>GSK-3<\/strong>, because a\u00a0<strong>GSK-3 inhibitor<\/strong>\u00a0already exists and holds tremendous promise in the fight against Alzheimer\u2019s. This\u00a0<strong>GSK-3 inhibitor<\/strong>\u00a0is the trace element\u00a0<em><strong>lithium<\/strong><\/em>.<\/p>\n<p>Even tiny amounts of lithium in drinking water appear to have a beneficial effect in improving brain health and mood.<\/p>\n<p>One published analysis looked at 27 counties in Texas with a variety of lithium levels in people\u2019s water from 1978-1987.<sup>60<\/sup>\u00a0The findings showed that people whose water had the least amount of lithium had significantly greater levels of suicides, homicides, and rapes compared to areas where drinking water had the\u00a0<strong><em>higher<\/em><\/strong>\u00a0levels of lithium.<sup>60<\/sup>\u00a0Those who consumed water with the highest lithium level (but still tiny) had nearly\u00a0<strong>40%<\/strong>\u00a0fewer suicides than those with the lowest lithium level.<sup>60<\/sup><\/p>\n<p>These findings were corroborated in separate studies of Japan,<sup>64<\/sup>\u00a0Greece,<sup>65<\/sup>\u00a0and Austria.<sup>66,67\u00a0<\/sup>A review of epidemiological studies of the\u00a0<strong>lithium content<\/strong>\u00a0of drinking water showed that 9 out of 11 studies found an association with higher lithium levels in local drinking water and better behavioral and medical outcomes.<sup>68<\/sup><\/p>\n<p>In clinical studies, lithium treatment has been linked to various markers of cellular neuroprotection in the brain, such as:<sup>70<\/sup><\/p>\n<ul>\n<li>\u00a0Cerebral cortex thickening<\/li>\n<li>Increased gray matter density, and<\/li>\n<li>Hippocampal (memory center) enlargement.<\/li>\n<\/ul>\n<p>However, like any mineral, high doses of lithium induce toxicity.\u00a0Psychiatric patients with\u00a0<strong>bipolar disorder<\/strong>\u00a0are typically prescribed lithium doses\u00a0<strong>3,000-4,000 times<\/strong>\u00a0higher than the microdoses (<strong>300 mcg<\/strong>) given to Alzheimer\u2019s patients over a 15-month study period. This tiny dose of lithium did not produce any of the side effects that psychiatric patients endure, nor would any side effects be expected.<\/p>\n<p>Lithium is considered a trace micronutrient with a suggested daily requirement of about\u00a0<strong>1,000 mcg<\/strong>.<sup>57<\/sup>\u00a0The problem is most people are not getting anything near this amount in their drinking water, especially if it is heavily filtered or distilled, which can remove all natural minerals.<\/p>\n<p>Based on the results of a 15-month Alzheimer\u2019s clinical trial where\u00a0<strong>dementia progression<\/strong>\u00a0was halted and no side effects observed, the daily microdose used in this study (<strong>300 mcg<\/strong>\u00a0per day) is a rational starting supplemental dose to suppress excess\u00a0<strong>GSK-3 activity<\/strong>\u00a0in our aging brains.<\/p>\n<h4><strong>Human Study Shows that Lithium Preserves Cognition<\/strong><\/h4>\n<p>Lithium at microdoses in humans shows\u00a0<strong>cognition-preserving<\/strong>\u00a0effects.<\/p>\n<p>A study involving\u00a0<strong>Alzheimer\u2019s<\/strong><strong>\u00a0<\/strong>patients was conducted using\u00a0<strong>microdose lithium<\/strong>, administered at\u00a0<strong>300 mcg<\/strong>\u00a0per day for 15 months.<sup>59<\/sup>\u00a0Cognitive impairment was evaluated by scores on the\u00a0<strong>Mini-Mental State Examination<\/strong>.<sup>63<\/sup><\/p>\n<p>At the outset of the study there were no significant differences in Mini-Mental State Examination scores between treated and control Alzheimer\u2019s subjects. The maximum Mini-Mental State Examination score is 30 points. A score of 20 to 24 suggests mild dementia, 13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia.<\/p>\n<p>By\u00a0<strong>90 days<\/strong>, statistical analysis revealed that Alzheimer\u2019s subjects treated with\u00a0 <strong>microdose<\/strong>\u00a0 <strong>lithium<\/strong>\u00a0 had cognitive performance scores that remained\u00a0<strong>stable<\/strong>, while patients taking the placebo experienced a decrease in cognitive performance scores. The\u00a0<strong>placebo<\/strong><strong>\u00a0<\/strong>group of\u00a0<strong>Alzheimer\u2019s<\/strong>\u00a0patients was approximately 3 points below the lithium-treated group (17.37 vs. 20.60) by the end of this initial 90 days, and by the end of the study, placebo controls were approximately 5 points below the lithium-treated Alzheimer\u2019s group (14 vs. 19.82).<sup>59<\/sup><\/p>\n<p>Basically, this study demonstrated that there was virtually <strong><em>no further<\/em><\/strong>\u00a0<strong>cognitive decline<\/strong>\u00a0during the study period in\u00a0<strong>Alzheimer\u2019s<\/strong>\u00a0patients supplemented with\u00a0<strong>microdose lithium<\/strong>.<\/p>\n<h4>Proline-Rich Polypeptide Reverses Neurologic Decline<\/h4>\n<p>Derived from mother\u2019s milk,\u00a0<strong>colostrum<\/strong>,<sup>43<\/sup>\u00a0a\u00a0<strong>proline-rich polypeptide<\/strong>, has been shown to influence\u00a0<strong>gene expression<\/strong>\u00a0in the immune system and brain.<\/p>\n<p>In a lab study,\u00a0<strong>proline-rich polypeptide<\/strong>\u00a0altered the expression of genes involved in\u00a0<em><strong>beta amyloid<\/strong><\/em>\u00a0protein production and in the changes to\u00a0<em><strong>tau proteins<\/strong><\/em>\u00a0that trigger formation of\u00a0<em><strong>neurofibrillary tangles<\/strong><\/em>.<\/p>\n<p>At the same time,\u00a0<strong>proline-rich polypeptide<\/strong>\u00a0altered the expression of genes to increase the production of <em><strong>enzymes<\/strong><\/em>\u00a0that break down and eliminate\u00a0<em><strong>beta amyloid<\/strong><\/em>\u00a0as part of the natural clearance process.<sup>42<\/sup><\/p>\n<p>This study demonstrated additional protective effects of\u00a0<strong>proline-rich polypeptide<\/strong>, including enhanced defenses against chemical stresses and decreased expression of cytokines that promote\u00a0<strong>inflammation<\/strong>, a process long implicated in Alzheimer\u2019s disease.<sup>42<\/sup><\/p>\n<p>Together, these properties of\u00a0<strong>proline-rich polypeptide<\/strong>\u00a0change the expression of molecular networks that lead to\u00a0<strong>beta amyloid<\/strong>\u00a0formation and\u00a0<strong>tau alterations<\/strong>. This\u00a0<strong>mother\u2019s milk<\/strong>-derived compound thus has the potential to prevent some of the fundamental\u00a0<strong>structural<\/strong>\u00a0causes of Alzheimer\u2019s disease!<\/p>\n<h4>Reversal of Cognitive Decline in Human Alzheimer\u2019s Patients<\/h4>\n<p>Compelling laboratory studies demonstrate that\u00a0<strong>proline-rich polypeptide<\/strong>, when applied to\u00a0<strong>nerve cells<\/strong>\u00a0growing in culture, triggers a cascade of events very similar to that produced by natural\u00a0<em><strong>nerve growth factor<\/strong><\/em>.<\/p>\n<p>These structural effects include important brain benefits such as enhanced\u00a0<em><strong>differentiation<\/strong><\/em><strong><em>\u00a0<\/em><\/strong>of premature cells into functioning adult neurons, and increased outgrowth of\u00a0<em><strong>neurites<\/strong><\/em>, the tiny projections on nerve cells where cell-to-cell communication takes place.<sup>43,44<\/sup><\/p>\n<p>Studies of anti-Alzheimer\u2019s drugs are considered successful when they show a slowing or stabilization of cognitive decline.<\/p>\n<p>Human studies of\u00a0colostrum-derived proline-rich polypeptide\u00a0are showing not only stabilization, but also\u00a0<em><strong>reversal<\/strong><\/em>\u00a0of brain dysfunction in those with early-stage disease.<\/p>\n<p>In one study, 46 patients with\u00a0<strong>Alzheimer\u2019s<\/strong>\u00a0were randomly assigned to receive, every second day, either\u00a0<strong>100 mcg<\/strong>\u00a0of colostrum-derived\u00a0<strong>proline-rich polypeptide<\/strong>, 100 mcg of selenium, or placebo tablets.<sup>72<\/sup>\u00a0 Subjects took the supplements for three weeks, followed by 2 weeks of no treatment, and repeated this cycle 10 times over the one-year trial. This dosing regimen was designed to maximize the impact of colostrum-derived\u00a0proline-rich polypeptide, which can lose effectiveness when taken continuously without a regular time-out interval.<sup>72<\/sup><\/p>\n<p>Subjects were then assessed by psychiatrists blinded to the treatment assignment of each patient, using the standard\u00a0<strong>Mini-Mental State Examination<\/strong>\u00a0score.<\/p>\n<p>In the\u00a0<strong>proline-rich polypeptide<\/strong>\u00a0group,\u00a0<strong>54%<\/strong>\u00a0of Alzheimer\u2019s patients showed <strong>improved scores<\/strong> (average improvement\u00a0<strong>25%<\/strong>). In the other\u00a0<strong>46%<\/strong>\u00a0of Alzheimer\u2019s patients receiving\u00a0proline-rich polypeptide, the dementia progression stabilized (did not worsen). Patients with milder Alzheimer\u2019s at the beginning of the study showed greater improvement than those who had more advanced disease, as is always the case, demonstrating the value of early intervention.<\/p>\n<p>In the selenium-treated group,\u00a0<strong>7%<\/strong>\u00a0of the patients saw improvement and\u00a0<strong>87%<\/strong>\u00a0stabilized.\u00a0In the unfortunate\u00a0<strong>placebo<\/strong>\u00a0group, Alzheimer\u2019s patients with mild and moderate disease saw their mental test scores decrease by<strong>36%<\/strong>\u00a0and\u00a0<strong>55%<\/strong>, respectively. Scores of placebo patients with the most severe Alzheimer\u2019s decreased by\u00a0<strong>31%<\/strong>.<sup>72<\/sup><\/p>\n<p>A second study by the same group of researchers, and using the same dose and dosing schedule, was performed to evaluate longer-term effects of treatment.<sup>73<\/sup>\u00a0In this study, however, no placebo group or selenium group was included.<\/p>\n<p>Treatment continued for 16 months, but included a group (1\/3 of the whole) who had participated in the\u00a0<em><strong>earlier<\/strong><\/em>\u00a0study, and so were in fact treated for a total of\u00a0<strong>28<\/strong>\u00a0months. By the end of the study, significant improvements in\u00a0<strong>Mini-Mental State Examination<\/strong>\u00a0scores were seen at each interval, compared with baseline values.<\/p>\n<p>The\u00a0<strong>mental test score<\/strong>\u00a0improvements of the Alzheimer\u2019s patients who received\u00a0<strong>proline-rich polypeptide<\/strong>\u00a0were substantial and in the absence of adverse side effects justify a trial for anyone concerned about their mental state, or anyone desiring extra insurance against Alzheimer\u2019s.<\/p>\n<p>Note: Other formulations that I have talked about on this site, namely Perceptiv\u2122 and Memoryze\u2122 also contain nutrients that have been shown to arrest the development of amyloid proteins and reduce the risk for tau tangles. \u00a0And overall, are probably better formulations for improving memory in most cases. However, this is much less expensive, and provides an added layer of protection (I now take both, plus others) addressing the same issues from a totally different direction.<\/p>\n<h4><strong>Summary <\/strong><\/h4>\n<p><strong>\u00a0<\/strong>The Life Extension report ends with the following:<\/p>\n<p>\u201cWhile no truly effective medication for Alzheimer\u2019s exists,<sup>74,75<\/sup>\u00a0<strong>lithium<\/strong>\u00a0and\u00a0<strong>proline-rich <\/strong><strong><em>polypeptide<\/em><\/strong>\u00a0contribute to potential prevention of the\u00a0<em><strong>structural<\/strong><\/em>\u00a0changes that contribute to Alzheimer\u2019s. They are safe enough for regular use over the long term, and should be included in a supplement regimen aimed at decelerating destructive aging processes.<\/p>\n<p>As described at the beginning of this article,\u00a0<strong>GSK-3<\/strong><strong>\u00a0<\/strong>inhibitors not only confer protection against neuronal\u00a0<strong>structural<\/strong>\u00a0changes, but may protect other cells in the body against age-associated deterioration.<\/p>\n<p>Based on the data uncovered in this article, if a pharmaceutical were developed that produced anywhere near these same clinical benefits, it would become a multibillion-dollar blockbuster drug that would cost consumers hundreds if not thousands of dollars per bottle. The cost of these two nutrients, on the other hand, is remarkably low\u2026less than\u00a0<strong>50 cents<\/strong><strong>\u00a0<\/strong>a day.\u201d<\/p>\n<p>If you would like to try this powerful yet inexpensive supplement I have arranged for you to obtain a discount. I would very much like to see what it can do for a variety of people. Just <strong><a href=\"https:\/\/www.levitamins.com\/16942\/Home\">\u00a0Click here<\/a><\/strong>. The product is called <strong><em>Memory Protect<\/em><\/strong>, you can\u2019t miss it, and for just $18 plus $5 postage, you can start the New Year with some very inexpensive insurance against AD!\u00a0 It may even help you live longer, as you maintain your healthy brain. \u00a0By the way, while you are at it, for just another $10 why not pick up a copy of my new book on <strong><em>How to Maintain A Healthy Brain<\/em><\/strong> \u00a0<strong><a href=\"http:\/\/4abettermemory.com\/memory\/buy-products\/\">by clicking here<\/a><\/strong>.<\/p>\n<p>Merry Christmas &amp; A Healthy New Year!<\/p>\n<h5>If you have any questions on the scientific content of this article, please call a\u00a0<strong>Life Extension<\/strong>\u00ae Wellness Specialist at\u00a01-866-864-3027. To read the original of this news release and access<\/h5>\n<h5><strong>references<\/strong> go to:<\/h5>\n<p><a href=\"http:\/\/www.lifeextension.com\/Magazine\/2016\/SS\/CoverBrainAging\/Page-01\">http:\/\/www.lifeextension.com\/Magazine\/2016\/SS\/CoverBrainAging\/Page-01<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is an adaptation of a recent news release from Life Extension Foundation, revealing a novel\u00a0low-cost\u00a0method of restoring\u00a0cognitive function lost to structural changes that can occur in aging brains, especially those with Alzheimer disease (AD). The primary biomarkers for AD are deformed amyloid proteins, associated with sticky plaque accumulations in the brain, and tangled strands [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1004","post","type-post","status-publish","format-standard","hentry","category-prevention-strategies"],"_links":{"self":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/1004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/comments?post=1004"}],"version-history":[{"count":9,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/1004\/revisions"}],"predecessor-version":[{"id":1013,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/posts\/1004\/revisions\/1013"}],"wp:attachment":[{"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/media?parent=1004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/categories?post=1004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/4abettermemory.com\/memory\/wp-json\/wp\/v2\/tags?post=1004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}